# Netscout Systems Inc: financial statements, quarterly

NTCT · Nasdaq · CIK 1078075 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ntct.md) · [Financials](/companies/ntct/financials.md) · [Filings](/companies/ntct/filings.md) · [Insiders](/companies/ntct/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntct/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [197](/filings/0001628280-24-044742.md) | [218](/filings/0001628280-25-004249.md) | [203 d](/filings/0001078075-26-000050.md) | [175](/filings/0001628280-25-038913.md) | [191](/filings/0001078075-25-000012.md) | [252](/filings/0001078075-26-000012.md) | [205 d](/filings/0001078075-26-000050.md) | [187](/filings/0001078075-26-000108.md) | [219](/filings/0001078075-25-000012.md) | [251](/filings/0001078075-26-000012.md) | [203 d](/filings/0001078075-26-000050.md) | [210](/filings/0001078075-26-000108.md) |
| Cost of revenue | $m | [43.1](/filings/0001628280-24-044742.md) | [43.6](/filings/0001628280-25-004249.md) | [50.3 d](/filings/0001078075-26-000050.md) | [44.4](/filings/0001628280-25-038913.md) | [42.1](/filings/0001078075-25-000012.md) | [46.6](/filings/0001078075-26-000012.md) | [45.7 d](/filings/0001078075-26-000050.md) | [43.4](/filings/0001078075-26-000108.md) | [43.6](/filings/0001078075-25-000012.md) | [46.0](/filings/0001078075-26-000012.md) | [43.9 d](/filings/0001078075-26-000050.md) | [44.5](/filings/0001078075-26-000108.md) |
| Gross profit | $m | [154](/filings/0001628280-24-044742.md) | [174](/filings/0001628280-25-004249.md) | [153 d](/filings/0001078075-26-000050.md) | [130](/filings/0001628280-25-038913.md) | [149](/filings/0001078075-25-000012.md) | [205](/filings/0001078075-26-000012.md) | [159 d](/filings/0001078075-26-000050.md) | [143](/filings/0001078075-26-000108.md) | [175](/filings/0001078075-25-000012.md) | [205](/filings/0001078075-26-000012.md) | [159 d](/filings/0001078075-26-000050.md) | [166](/filings/0001078075-26-000108.md) |
| Research and development | $m | [35.1](/filings/0001628280-24-044742.md) | [37.0](/filings/0001628280-25-004249.md) | [43.6 d](/filings/0001078075-26-000050.md) | [42.5](/filings/0001628280-25-038913.md) | [35.9](/filings/0001078075-25-000012.md) | [37.8](/filings/0001078075-26-000012.md) | [36.7 d](/filings/0001078075-26-000050.md) | [39.8](/filings/0001078075-26-000108.md) | [40.3](/filings/0001078075-25-000012.md) | [39.6](/filings/0001078075-26-000012.md) | [39.8 d](/filings/0001078075-26-000050.md) | [42.4](/filings/0001078075-26-000108.md) |
| Operating income | $m | [26.3](/filings/0001628280-24-044742.md) | [(134)](/filings/0001628280-25-004249.md) | [(37.0) d](/filings/0001078075-26-000050.md) | [(463)](/filings/0001628280-25-038913.md) | [14.1](/filings/0001078075-25-000012.md) | [61.7](/filings/0001078075-26-000012.md) | [19.9 d](/filings/0001078075-26-000050.md) | [(6.6)](/filings/0001078075-26-000108.md) | [32.5](/filings/0001078075-25-000012.md) | [64.3](/filings/0001078075-26-000012.md) | [19.6 d](/filings/0001078075-26-000050.md) | [14.5](/filings/0001078075-26-000108.md) |
| Interest expense | $m | [2.2](/filings/0001628280-23-036391.md) | [2.2](/filings/0001628280-24-003860.md) | [2.2 d](/filings/0001628280-24-023777.md) | [1.9](/filings/0001628280-25-038913.md) | [1.8](/filings/0001078075-25-000012.md) | [2.6](/filings/0001078075-26-000012.md) | [0.8 d](/filings/0001078075-26-000050.md) | [0.4](/filings/0001078075-26-000108.md) | [0.4](/filings/0001078075-25-000012.md) | [0.5](/filings/0001078075-26-000012.md) | [0.4 d](/filings/0001078075-26-000050.md) | [0.4](/filings/0001078075-26-000108.md) |
| Income tax | $m | [6.0](/filings/0001628280-24-044742.md) | [(1.1)](/filings/0001628280-25-004249.md) | [(0.5) d](/filings/0001078075-26-000050.md) | [(10.3)](/filings/0001628280-25-038913.md) | [3.3](/filings/0001078075-25-000012.md) | [8.6](/filings/0001078075-26-000012.md) | [(0.4) d](/filings/0001078075-26-000050.md) | [0.9](/filings/0001078075-26-000108.md) | [5.6](/filings/0001078075-25-000012.md) | [11.5](/filings/0001078075-26-000012.md) | [5.1 d](/filings/0001078075-26-000050.md) | [(2.9)](/filings/0001078075-26-000108.md) |
| Net income | $m | [21.5](/filings/0001628280-24-044742.md) | [(133)](/filings/0001628280-25-004249.md) | [(32.4) d](/filings/0001078075-26-000050.md) | [(443)](/filings/0001628280-25-038913.md) | [9.0](/filings/0001078075-25-000012.md) | [48.8](/filings/0001078075-26-000012.md) | [18.6 d](/filings/0001078075-26-000050.md) | [(3.7)](/filings/0001078075-26-000108.md) | [25.8](/filings/0001078075-25-000012.md) | [55.1](/filings/0001078075-26-000012.md) | [18.2 d](/filings/0001078075-26-000050.md) | [21.8](/filings/0001078075-26-000108.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001628280-24-044742.md) | [(1.87)](/filings/0001628280-25-004249.md) | not reported | [(6.20)](/filings/0001628280-25-038913.md) | [0.13](/filings/0001078075-25-000012.md) | [0.67](/filings/0001078075-26-000012.md) | not reported | [(0.05)](/filings/0001078075-26-000108.md) | [0.35](/filings/0001078075-25-000012.md) | [0.75](/filings/0001078075-26-000012.md) | not reported | [0.29](/filings/0001078075-26-000108.md) |
| Basic EPS | $ per share | [0.30](/filings/0001628280-24-044742.md) | [(1.87)](/filings/0001628280-25-004249.md) | not reported | [(6.20)](/filings/0001628280-25-038913.md) | [0.13](/filings/0001078075-25-000012.md) | [0.68](/filings/0001078075-26-000012.md) | not reported | [(0.05)](/filings/0001078075-26-000108.md) | [0.36](/filings/0001078075-25-000012.md) | [0.76](/filings/0001078075-26-000012.md) | not reported | [0.30](/filings/0001078075-26-000108.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [280](/filings/0001628280-23-036391.md) | [298](/filings/0001628280-24-003860.md) | [390](/filings/0001628280-25-025982.md) | [362](/filings/0001628280-24-034721.md) | [363](/filings/0001628280-24-044742.md) | [398](/filings/0001628280-25-004249.md) | [457](/filings/0001078075-26-000050.md) | [490](/filings/0001628280-25-038913.md) | [483](/filings/0001078075-25-000012.md) | [541](/filings/0001078075-26-000012.md) | [586](/filings/0001078075-26-000108.md) | [553](/filings/0001078075-26-000108.md) |
| Current assets | $m | [541](/filings/0001628280-23-036391.md) | [609](/filings/0001628280-24-003860.md) | [672](/filings/0001628280-25-025982.md) | [590](/filings/0001628280-24-034721.md) | [584](/filings/0001628280-24-044742.md) | [692](/filings/0001628280-25-004249.md) | [713](/filings/0001078075-26-000050.md) | [684](/filings/0001628280-25-038913.md) | [708](/filings/0001078075-25-000012.md) | [857](/filings/0001078075-26-000012.md) | [868](/filings/0001078075-26-000108.md) | [772](/filings/0001078075-26-000108.md) |
| Total assets | $m | [2,698](/filings/0001628280-23-036391.md) | [2,590](/filings/0001628280-24-003860.md) | [2,595](/filings/0001628280-25-025982.md) | [2,085](/filings/0001628280-24-034721.md) | [2,071](/filings/0001628280-24-044742.md) | [2,175](/filings/0001628280-25-004249.md) | [2,187](/filings/0001078075-26-000050.md) | [2,157](/filings/0001628280-25-038913.md) | [2,176](/filings/0001078075-25-000012.md) | [2,322](/filings/0001078075-26-000012.md) | [2,355](/filings/0001078075-26-000108.md) | [2,311](/filings/0001078075-26-000108.md) |
| Current liabilities | $m | [359](/filings/0001628280-23-036391.md) | [382](/filings/0001628280-24-003860.md) | [395](/filings/0001628280-25-025982.md) | [383](/filings/0001628280-24-034721.md) | [347](/filings/0001628280-24-044742.md) | [382](/filings/0001628280-25-004249.md) | [408](/filings/0001078075-26-000050.md) | [387](/filings/0001628280-25-038913.md) | [377](/filings/0001078075-25-000012.md) | [443](/filings/0001078075-26-000012.md) | [470](/filings/0001078075-26-000108.md) | [423](/filings/0001078075-26-000108.md) |
| Total liabilities | $m | [658](/filings/0001628280-23-036391.md) | [686](/filings/0001628280-24-003860.md) | [703](/filings/0001628280-25-025982.md) | [653](/filings/0001628280-24-034721.md) | [611](/filings/0001628280-24-044742.md) | [654](/filings/0001628280-25-004249.md) | [626](/filings/0001078075-26-000050.md) | [610](/filings/0001628280-25-038913.md) | [603](/filings/0001078075-25-000012.md) | [680](/filings/0001078075-26-000012.md) | [705](/filings/0001078075-26-000108.md) | [648](/filings/0001078075-26-000108.md) |
| Long-term debt | $m | [100](/filings/0001628280-23-036391.md) | [100](/filings/0001628280-24-003860.md) | [100](/filings/0001628280-25-025982.md) | [75.0](/filings/0001628280-24-034721.md) | [75.0](/filings/0001628280-24-044742.md) | [75.0](/filings/0001628280-25-004249.md) | [0.0](/filings/0001628280-25-025982.md) | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,040](/filings/0001628280-25-004249.md) | [1,904](/filings/0001628280-25-004249.md) | [1,892](/filings/0001078075-26-000050.md) | [1,432](/filings/0001078075-25-000012.md) | [1,459](/filings/0001078075-26-000012.md) | [1,521](/filings/0001078075-26-000012.md) | [1,560](/filings/0001078075-26-000108.md) | [1,548](/filings/0001078075-26-000108.md) | [1,574](/filings/0001078075-26-000012.md) | [1,641](/filings/0001078075-26-000012.md) | [1,649](/filings/0001078075-26-000108.md) | [1,663](/filings/0001078075-26-000108.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(26.4) d](/filings/0001628280-24-044742.md) | [14.0 d](/filings/0001628280-25-004249.md) | [93.6 d](/filings/0001078075-26-000050.md) | [38.4](/filings/0001628280-25-038913.md) | [(3.7) d](/filings/0001078075-25-000012.md) | [41.5 d](/filings/0001078075-26-000012.md) | [142 d](/filings/0001078075-26-000050.md) | [73.6](/filings/0001078075-26-000108.md) | [6.7 d](/filings/0001078075-25-000012.md) | [62.1 d](/filings/0001078075-26-000012.md) | [152 d](/filings/0001078075-26-000050.md) | [50.8](/filings/0001078075-26-000108.md) |
| Capital expenditure | $m | [1.5 d](/filings/0001628280-24-044742.md) | [1.2 d](/filings/0001628280-25-004249.md) | [1.6 d](/filings/0001078075-26-000050.md) | [1.3](/filings/0001628280-25-038913.md) | [0.9 d](/filings/0001078075-25-000012.md) | [1.9 d](/filings/0001078075-26-000012.md) | [1.4 d](/filings/0001078075-26-000050.md) | [1.9](/filings/0001078075-26-000108.md) | [2.2 d](/filings/0001078075-25-000012.md) | [2.8 d](/filings/0001078075-26-000012.md) | [2.2 d](/filings/0001078075-26-000050.md) | [3.5](/filings/0001078075-26-000108.md) |
| Share repurchases | $m | [31.1 d](/filings/0001628280-24-044742.md) | [18.9 d](/filings/0001628280-25-004249.md) | [0.0 d](/filings/0001078075-26-000050.md) | [25.0](/filings/0001628280-25-038913.md) | [0.3 d](/filings/0001078075-25-000012.md) | [0.0 d](/filings/0001078075-26-000012.md) | [0.0 d](/filings/0001078075-26-000050.md) | [15.0](/filings/0001078075-26-000108.md) | [16.6 d](/filings/0001078075-25-000012.md) | [0.0 d](/filings/0001078075-26-000012.md) | [29.2 d](/filings/0001078075-26-000050.md) | [0.0](/filings/0001078075-26-000108.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.9](/filings/0001628280-23-036391.md) | [73.0](/filings/0001628280-24-003860.md) | [71.5](/filings/0001628280-24-034721.md) | [72.8](/filings/0001628280-24-044742.md) | [71.1](/filings/0001628280-25-004249.md) | [71.5](/filings/0001628280-25-038913.md) | [71.8](/filings/0001078075-25-000012.md) | [72.6](/filings/0001078075-26-000012.md) | [71.7](/filings/0001078075-26-000108.md) | [72.9](/filings/0001078075-25-000012.md) | [73.8](/filings/0001078075-26-000012.md) | [74.6](/filings/0001078075-26-000108.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,707,312 at 2026-07-28, from the cover of the [10-Q filed 2026-08-06](/filings/0001078075-26-000108.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.